Physician profile
Mary Cay Koen
NPI 1821113564
$4,726.09
in general payments reported to CMS, 2019-2025
9 companies · $463 in 2025
The $463 reported for 2025 was more than what 79% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.85 · 2020: $101 · 2021: $467 · 2022: $2,692 · 2023: $414 · 2024: $544 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Organizers, INC. | $2,542.56 | 2020-2022 | |
| Align Technology, INC. | $875.14 | 2019-2025 | Invisalign, Itero Element, Itero Element 5d |
| Ormco Corporation | $493.63 | 2019-2023 | Spark |
| Envista Holdings Corporation | $382.52 | 2024-2025 | Spark |
| Dental Monitoring Sas | $263.15 | 2025 | |
| Nobel Biocare USA | $107.18 | 2023 | Nobelactive |
| Philips North America LLC | $27.07 | 2019-2024 | (3110) Oral Health Care Und |
| Dentsply Sirona INC | $25.85 | 2021 | |
| American Orthodontics Corporation | $8.99 | 2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Koen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.